Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain

Science

Volumn 196, Issue 4287, 1977, Pages 326-328

  Burt, David R ^a,b   Creese, I A N ^a   Snyder, Solomon H ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR; FLUPHENAZINE; HALOPERIDOL; PROMETHAZINE; RESERPINE;

BRAIN; CORPUS STRIATUM; CYTOLOGY; DRUG MECHANISM; DRUG THERAPY; HALOPERIDOL H 3; INTRAPERITONEAL DRUG ADMINISTRATION; RAT; SCHIZOPHRENIA; TARDIVE DYSKINESIA; THEORETICAL STUDY;

ANIMAL; APOMORPHINE; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUPHENAZINE; HALOPERIDOL; KINETICS; RATS; RECEPTORS, DOPAMINE; RESERPINE; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TRANQUILIZING AGENTS;

EID: 0017599705     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.847477     Document Type: Article

References (0)